BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valenti MT, Serena M, Carbonare LD, Zipeto D. CRISPR/Cas system: An emerging technology in stem cell research. World J Stem Cells 2019; 11(11): 937-956 [PMID: 31768221 DOI: 10.4252/wjsc.v11.i11.937] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mehta KJ. Iron Oxide Nanoparticles in Mesenchymal Stem Cell Detection and Therapy. Stem Cell Rev Rep 2022. [PMID: 35103937 DOI: 10.1007/s12015-022-10343-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Sobti RC, Rai J, Prakash A. Introduction to Emerging Technologies in Biomedical Sciences. Biomedical Translational Research 2022. [DOI: 10.1007/978-981-16-4345-3_1] [Reference Citation Analysis]
3 Sobti RC, Ali A, Dolma P, Kadwalia A, Dolma T, Rai J, Chauhan A. Emerging techniques in biological sciences. Advances in Animal Experimentation and Modeling 2022. [DOI: 10.1016/b978-0-323-90583-1.00013-1] [Reference Citation Analysis]
4 Mohan N, Qiang L, Morfini G, Baas PW. Therapeutic Strategies for Mutant SPAST-Based Hereditary Spastic Paraplegia. Brain Sci 2021;11:1081. [PMID: 34439700 DOI: 10.3390/brainsci11081081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 McKnight CL, Low YC, Elliott DA, Thorburn DR, Frazier AE. Modelling Mitochondrial Disease in Human Pluripotent Stem Cells: What Have We Learned? Int J Mol Sci 2021;22:7730. [PMID: 34299348 DOI: 10.3390/ijms22147730] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
6 Kalita E. A REVIEW ON THE APPLICATION OF CRISPR/Cas9-GENOME EDITING TOOL. IJAR 2021. [DOI: 10.36106/ijar/2611035] [Reference Citation Analysis]
7 Sar P, Dalai S. CRISPR/Cas9 in epigenetics studies of health and disease. Prog Mol Biol Transl Sci 2021;181:309-43. [PMID: 34127198 DOI: 10.1016/bs.pmbts.2021.01.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Hirata M, Wittayarat M, Namula Z, Le QA, Lin Q, Nguyen NT, Takebayashi K, Sato Y, Tanihara F, Otoi T. Evaluation of multiple gene targeting in porcine embryos by the CRISPR/Cas9 system using electroporation. Mol Biol Rep 2020;47:5073-9. [PMID: 32519310 DOI: 10.1007/s11033-020-05576-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
9 Rai N, Singh AK, Singh SK, Gaurishankar B, Kamble SC, Mishra P, Kotiya D, Barik S, Atri N, Gautam V. Recent technological advancements in stem cell research for targeted therapeutics. Drug Deliv and Transl Res 2020;10:1147-69. [DOI: 10.1007/s13346-020-00766-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Burmistrz M, Krakowski K, Krawczyk-Balska A. RNA-Targeting CRISPR-Cas Systems and Their Applications. Int J Mol Sci 2020;21:E1122. [PMID: 32046217 DOI: 10.3390/ijms21031122] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 16.0] [Reference Citation Analysis]
11 Liu Z. CRISPR/Cas9 high-throughput screening in cancer research. E3S Web Conf 2020;185:03032. [DOI: 10.1051/e3sconf/202018503032] [Reference Citation Analysis]